DERIVATIZED DENDRIMER WITH LOW CITOTOXICITY FOR IN VIVO, EX VIVO, IN VITRO OR IN SITU CHELATION OF HEAVY METALS OR ACTINIDES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150148415A1
SERIAL NO

14087727

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention considers derivatized nanomolecules with proven effectiveness to bind to actinides, more specifically uranium, during in vivo, ex vivo, in vitro or in situ assays. When assayed in vivo, the invention showed a reduction in at least kidney damage due to exposition to uranium.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSIDAD DE TALCATALCA CP 3461891
FUNDACION FRAUNHOFER CHILE RESEARCHSANTIAGO 7550296

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
FISCHER, Rainer Aachen, DE 79 595
GUZMAN, Luis Talca, CL 3 2
NACHTIGALL, Fabiane M Talca, CL 5 36
SILVA, SANTOS Leonardo Talca, CL 3 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation